Related Experiment Video

Updated: Nov 20, 2025

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1
13:15

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1

Published on: February 25, 2016

12.2K

CDK5 inhibition protects against OGDR induced mitochondrial fragmentation and apoptosis through regulation of

Chunli Chen1, Xiaoxia Peng2, Jiayu Tang3

  • 1Department of Neurology, Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.

Life Sciences
|January 21, 2021
PubMed
Abstract

Insights

Inhibition of Cyclin-dependent kinase 5 (CDK5) protects against cerebral ischemia by regulating Dynamin-related protein 1 (Drp1) phosphorylation. This neuroprotection is dependent on Drp1S616 phosphorylation, offering a potential therapeutic target.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cell Biology

Background:

  • Cerebral ischemia poses a significant health challenge.
  • Cyclin-dependent kinase 5 (CDK5) is implicated in neuronal regulation.
  • CDK5 influences Dynamin-related protein 1 (Drp1) phosphorylation.

Purpose of the Study:

  • To investigate the neuroprotective role of CDK5 inhibition in cerebral ischemia.
  • To determine if CDK5 inhibition confers neuroprotection via regulation of Drp1 phosphorylation.
  • To elucidate the specific role of Drp1S616 phosphorylation in CDK5-mediated neuroprotection.

Main Methods:

  • Utilized mouse neuroblastoma cell lines (N2a, N1E-115) subjected to oxygen-glucose deprivation/reperfusion (OGDR).
  • Administered Roscovitine (CDK5 inhibitor) or CDK5 siRNA to inhibit CDK5 activity.
  • Analyzed protein expression (CDK5, p35, Drp1, p-Drp1S616) via western blot.
  • Assessed mitochondrial morphology and apoptosis using immunofluorescence and flow cytometry.

Main Results:

  • CDK5, p35, and p-Drp1S616 were upregulated post-OGDR.
  • CDK5 inhibition significantly reduced OGDR-induced mitochondrial fragmentation and apoptosis.
  • Overexpression of a phosphorylation-mimic Drp1 mutant (Drp1S616D) abolished the protective effects of CDK5 inhibition.

Conclusions:

  • CDK5 inhibition confers neuroprotection in cerebral ischemia models.
  • The neuroprotective mechanism is dependent on the phosphorylation status of Drp1 at serine 616.
  • Targeting CDK5 signaling offers a promising therapeutic strategy for cerebral ischemia.
Keywords:
Cyclin-dependent kinase 5 (CDK5)Dynamin-related protein 1 (Drp1)MitochondriaOxygen-glucose deprivation/reperfusion (OGDR)Phosphorylation

More Related Videos

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes15:43

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes

Published on: January 7, 2013

18.4K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.6K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.3K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.0K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
6.2K
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
119.3K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.7K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
37.5K